|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The RANK/RANKL/OPG triad in cancer induced bone diseases显示文摘 | Dougall WC Chaisson M | 2006 | Cancer Metastasis Rev2006，25，4： | 1 |
| 2 | Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin- 1, and tumor necrosis factor 显示文摘 | Visner GA Dougall WC Wilson JM | 1990 | J Biol Chem1990，265，5： | 1 |
| 3 | The novel receptor TRAIL-R4 induced NF-kappaB and pro tects against TRAIL mediated apoptosis, yct retains an incomplete death domain显示文摘 | Degli-Esposti MA Dougall WC Smolak PJ | | 0，，： | 1 |
| 4 | RANK isessential for osteoclast and lymphnode development显示文摘 | Dougall WC Glaccum M Charrier K | 1999 | Genes Dev1999，13，18： | 1 |
| 5 | The RANK/RANKL/OPG triad in cancer-induced bone diseases 显示文摘 | Dougall WC Chaisson M | 2006 | Cancer Metastasis Rev2006，25，4： | 1 |
| 6 | The novel receptor TRAIL - R4 induces NF - kappaB and protects against TRAIL - mediated apoptosis, yet retains an incomplete death domain显示文摘 | Degli- Esposti MA Dougall WC Smolak PJ | 1997 | Immunity1997，7，6： | 1 |
| 7 | The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis,yet retains an incomplete death domain显示文摘 | Degli-Esposti MA Dougall WC Smolak PJ | 1997 | Immunity1997，7，6： | 1 |
| 8 | RANK ligand as a therapeutic target for bone metastases and multiple myeloma显示文摘 | Roodman GD Dougall WC | 2008 | Cancer Treat Rev2008，34，1： | 1 |
| 9 | The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB,a m ember of t he T NFR s uperfamily显示文摘 | Galibert L Tometsko ME Anderson DM Cosman D Dougall WC | | 0，，： | 1 |
| 10 | A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function显示文摘 | Armstrong AP Tometsko ME Glaccum M Sutherland CL Cosman D Dougall WC | | 0，，： | 1 |
| 11 | The RANK/RANKL/OPG triad in cancer-induced bone diseases显示文摘 | Dougall WC Chaisson M | 2006 | Cancer Metastasis Rev2006，25，： | 1 |
| 12 | Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation显示文摘 | Samanta A LeVea CM Dougall WC | 1994 | Proc Natl Acad Sci U S A1994，91，5： | 1 |
| 13 | The novel receptor TRAIL-R4 induces NF-kB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain 显示文摘 | Degli-Esposti MA Dougall WC Smolak PJ | 1997 | Immunity1997，7，4： | 1 |
| 14 | The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain显示文摘 | Degli-Esposti MA Dougall WC Smolak PJ | 1997 | Immunity1997，7，6： | 1 |
| 15 | The RANK/RANKL/OPG triad in cancer-induced bone diseases显示文摘 | Dougall WC Chaisson M | 2006 | Cancer Metastasis Rev2006，25，4： | 1 |
| 16 | The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis,yet retains an incomplete death domain显示文摘 | Degli-Esposti MA Dougall WC Smolak PJ | 1997 | Immunity1997，7，6： | 1 |
| 17 | RANK is essential for osteoclast and lymph node development显示文摘 | Dougall WC Glaccam M Charrier K | 1999 | Genes Dev1999，13，18： | 1 |
| 18 | RANK is essential for osteoclast and lymph node development显示文摘 | Dougall WC Glaccum M Charrier K | 1999 | Genes Dev1999，13，18： | 1 |
| 19 | RANK ligand as a therapeutic target for bone metastases and multiple myeloma显示文摘 | GD Roodman WC Dougall | 2008 | Cancer Treat Rev2008，34，1： | 1 |
| 20 | Effects of the RANKL inhibitor,osteoprotegerin,on the pain and histopathology of bone cancer in rats显示文摘 | Roudier MP Bain SD Dougall WC | | 0，，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员